杂志简称:j clin psychopharm
中文译名:《临床精神药理学杂志》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:7.50%
投稿方向:医学、pharmacology & pharmacy 药学、psychiatry 精神病学
SCI/E期刊基本信息
出版周期:双月刊 地区:美国
中科院分区:3区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN0271-0749;EISSN1533-712X
杂志语言:英语
出版国家:美国
杂志官网 联系方式
出版地址:LIPPINCOTT WILLIAMS & WILKINS,530 WALNUT ST,PHILADELPHIA,USA,PA,19106-3621
杂志邮箱:
投稿网址:https://www.editorialmanager.com/jcp/
杂志官方网址:https://journals.lww.com/psychopharmacology/pages/default.aspx
出版商网址:http://www.lww.com/
杂志投稿要求
投稿须知【杂志社官方网站信息】
Instructions for Authors
SCOPE
The Journal of Clinical Psychopharmacology is a peer-reviewed journal intended for practicing clinicians and trainees interested in improving their knowledge and in keeping up with the changing world of clinical psychopharmacology. The scope of the Journal includes clinical trials and studies, side effects and other adverse reactions, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and the psychiatric effects of nonpsychiatric drugs. Problems of special populations (the elderly, children, adolescents, pregnant women, and minorities) are of particular concern.
Clinicians and researchers are invited to submit their findings and observations to the following sections: Original Contributions (clinically relevant investigations, and animal work with direct applicability to clinical care), Brief Reports (condensed research findings), Review Articles, and Letters to the Editors (including Case Reports). Authors must submit manuscripts online through the journal's Web site at http://jcp.edmgr.com/. See submission instructions below under "Manuscript submission."
Ethical/Legal Considerations: A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity is carefully protected. Authors must verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. If consent was not written, explain why. Further instructions are provided below with respect to the submission of case reports.
Original Studies: The Journal requires authors to affirm that all original studies submitted for publication have been carried out in accordance with the Declaration of Helsinki and/or with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health.